Literature DB >> 30195140

Immunomodulatory properties of chitosan polymers.

Hannah B T Moran1, Joanna L Turley1, Mats Andersson2, Ed C Lavelle3.   

Abstract

The introduction of vaccines is regarded as one of the most successful medical interventions to date. However, there is a clear need for the development of new vaccines for diseases which require the induction of a potent cellular immune response. Advancements in the field of vaccine research have resulted in a move away from the use of whole organisms and towards the use of subunit vaccines which consist of highly purified antigens with an improved safety profile. Adjuvants are immunostimulatory components that are included in subunit vaccine formulations to help direct and amplify adaptive immune responses. Chitosan is a cationic polysaccharide that has been examined in an adjuvant setting due to its biocompatible and biodegradable nature. The polysaccharide has been shown to have the capacity to induce Th1 cell responses following vaccination by injection or mucosal routes, supporting its application as an alternative to alum for vaccines that promote cell-mediated immunity. Here, we provide an overview of the physico-chemical properties of chitosan with a focus on the specific characteristics that dictate the type and scale of the immune responses induced. The potential to finely tailor chitosan polymers in order to direct specific types of immune responses can provide invaluable tools for the design of novel chitosan-based adjuvants and biomaterials.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; Cellular immunity; Chitosan; Innate immunity; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 30195140     DOI: 10.1016/j.biomaterials.2018.08.054

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  23 in total

1.  In Vitro Antiprotozoal Effects of Nano-chitosan on Plasmodium falciparum, Giardia lamblia and Trichomonas vaginalis.

Authors:  Taher Elmi; Bahman Rahimi Esboei; Fatemeh Sadeghi; Zahra Zamani; Mojtaba Didehdar; Mahdi Fakhar; Aroona Chabra; Fateme Hajialiani; Mohammad Javad Namazi; Fatemeh Tabatabaie
Journal:  Acta Parasitol       Date:  2020-07-14       Impact factor: 1.440

2.  A combined inactivated cholera and hepatitis A vaccine-induced potent protective immunity in a mouse model.

Authors:  Nourhan H AbdelAllah; Ahmed F Azmy; Mohamed E Rashed; Sameh AbdelGhani; Yasser Gaber
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-21       Impact factor: 5.560

Review 3.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

Review 4.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

Review 5.  Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections.

Authors:  Monica C Gestal; Hannah M Johnson; Eric T Harvill
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

6.  High- and low-molecular-weight chitosan act as adjuvants during single-dose influenza A virus protein vaccination through distinct mechanisms.

Authors:  Anna T Lampe; Eric J Farris; Deborah M Brown; Angela K Pannier
Journal:  Biotechnol Bioeng       Date:  2020-12-16       Impact factor: 4.530

Review 7.  Polymeric nanoparticle vaccines to combat emerging and pandemic threats.

Authors:  David Wibowo; Sytze H T Jorritsma; Zennia Jean Gonzaga; Benjamin Evert; Shuxiong Chen; Bernd H A Rehm
Journal:  Biomaterials       Date:  2020-12-10       Impact factor: 12.479

Review 8.  Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view.

Authors:  Xingyue Huang; Yang Lu; Mingxue Guo; Shouying Du; Ning Han
Journal:  Theranostics       Date:  2021-06-04       Impact factor: 11.556

9.  Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory.

Authors:  Shuhong Qi; Lisen Lu; Feifan Zhou; Yuzhou Chen; Mengli Xu; Lu Chen; Xiang Yu; Wei R Chen; Zhihong Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 10.  Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.

Authors:  Philippe M Loiseau; Sébastien Pomel; Simon L Croft
Journal:  Molecules       Date:  2020-09-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.